Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up

Jazyk angličtina Země Velká Británie, Anglie Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid15604339

OBJECTIVE: To examine coagulation factors and liver function test abnormalities in patients after total cavopulmonary connection (TCPC). DESIGN: Cross sectional study comprising clinical and echocardiographic evaluation, and biochemical and coagulation profile screening. SETTING: Tertiary referral centre. METHODS: 102 patients aged 4-24 years (median 10 years) at one to eight years (median five years) after TCPC were examined. All patients were maintained on a low dose of aspirin. 96% of patients were in a good clinical condition (New York Heart Association class I or II). No intracardiac thrombi were detected on echocardiography and ventricular function was good in 91% of patients. RESULTS: Total bilirubin was increased in 27% and gamma glutamyltransferase in 54% of patients. Serum total protein, albumin, and prealbumin were normal in almost in all patients. Compared with the control group, patients after TCPC had significantly lower fibrinogen, factor V, factor VII, and protein C concentrations, prolonged international normalised ratio, and increased antithrombin III concentration. Factor V concentration was abnormally decreased in 35%, factor VII in 16%, and protein C in 28% of patients. Antithrombin III was increased in 23% of patients. Factor VII, factor V, protein C, and antithrombin III correlated significantly with serum prealbumin. There was also a significant correlation between procoagulant factor VII and both anticoagulant protein C and antithrombin III. CONCLUSIONS: Almost half of patients after TCPC had laboratory signs of mild cholestasis. Decreased liver synthesis of procoagulant and anticoagulant factors was observed but overall coagulation homeostasis appeared to be in balance in this selected group of patients with a good clinical outcome.

Zobrazit více v PubMed

Kaulitz R, Luhmer I, Bergmann F, et al. Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart 1997;78:154–9. PubMed PMC

Stamm C, Friehs I, Mayer JE Jr, et al. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 2001;121:28–41. PubMed

Naschitz JE, Slobodin G, Lewis RJ, et al. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 2000;140:111–20. PubMed

Mace S, Borkat G, Liebman J. Hepatic dysfunction and cardiovascular abnormalities: occurrence in infants, children, and young adults. Am J Dis Child 1985;139:60–5. PubMed

Cromme-Dijkhuis AH, Hess J, Hahlen K, et al. Specific sequelae after Fontan operation at mid- and long-term follow-up. J Thorac Cardiovasc Surg 1993;106:1126–32. PubMed

Cromme-Dijkhuis AH, Henkens CM, Bijleveld CM, et al. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations. Lancet 1990;336:1087–90. PubMed

van Nieuwenhuizen RC, Peters M, Lubbers LJ, et al. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 1999;82:40–6. PubMed PMC

Tomita H, Yamada O, Ohuchi H, et al. Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young 2001;11:62–6. PubMed

Rauch R, Ries M, Hofbeck M, et al. Hemostatic changes following the modified Fontan operation (total cavopulmonary connection). Thromb Haemost 2000;83:678–82. PubMed

Jahangiri M, Shore D, Kakkar V, et al. Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 1997;113:989–92. PubMed

Jahangiri M, Kreutzer J, Zurakowski D, et al. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 2000;120:778–82. PubMed

Ravn HB, Hjortdal VE, Stenbog EV, et al. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection. Heart 2001;85:61–5. PubMed PMC

Odegard KC, McGowan FX Jr, Zurakowski D, et al. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 2003;125:1260–7. PubMed

Andrew M, Vegh P, Johnston M. Maturation of the hemostatic system during childhood. Blood 1992;80:1998–2005. PubMed

Monagle P, Andrew M. Coagulation abnormalities after Fontan procedures. J Thorac Cardiovasc Surg 1998;115:732–3. PubMed

Barnes C, Monagle P. Haemostatic changes following the modified Fontan procedure. Thromb Haemost 2001;86:1341–2. PubMed

Martinez J, Barsigian C. Coagulopathy of liver failure and vitamin K deficiency. In: Loscalzo J, Schafer AI, eds. Thrombosis and hemorrhage. Baltimore: Williams & Wilkins, 1998:987–1004.

Amitrano L, Guardascione MA, Brancaccio V, et al. Coagulation disorders in liver disease. Semin Liver Dis 2002;22:83–96. PubMed

Narkewicz MR, Sondheimer HM, Ziegler JW, et al. Hepatic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr 2003;36:352–7. PubMed

Monagle P, Cochrane A, McCrindle B, et al. Thromboembolic complications after Fontan procedures: the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 1998;115:493–8. PubMed

Balling G, Vogt M, Kaemmerer H, et al. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg 2000;119:745–52. PubMed

Rosenthal DN, Bulbul ZR, Friedman AH, et al. Thrombosis of the pulmonary artery stump after distal ligation. J Thorac Cardiovasc Surg 1995;110:1563–5. PubMed

Odegard KC, McGowan FX Jr, Zurakowski D, et al. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 2002;73:1770–7. PubMed

Odegard KC, McGowan FX Jr, DiNardo JA, et al. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure. J Thorac Cardiovasc Surg 2002;123:459–65. PubMed

Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo: a closer look. Thromb Haemost 2001;86:855–61. PubMed

Rychik J, Gui-Yang S. Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. Am J Cardiol 2002;90:672–4. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...